Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Connected Government
- Consolidating Mission-critical Systems
- Constituent Servicing
- Continuous Monitoring: Tools and Techniques for Trustworthy Government IT
- The Data Privacy Imperative: Safeguarding Sensitive Data
- Eliminating the Pitfalls: Steps to Virtualization in Government
- Federal Executive Forum
- Federal Tech Talk
- Government Cloud Brokerage: Who, What, When, Where, Why?
- Government Mobility
- Mission-critical Apps in the Cloud
- Mobile Device Management
- The Modern Federal Threat Landscape
- The Path from Legacy Systems
- Understanding the Intersection of Customer Service and Security in the Cloud
Shows & Panels
FDA approves flu vaccine for coming season
Monday - 8/13/2012, 4:18pm EDT
WASHINGTON (AP) - The Food and Drug Administration says it has approved the new flu vaccine for the season beginning this year.
Each year the FDA works with other federal agencies and global health experts to design a vaccine to protect against the three viral strains most likely to cause the flu. This year's vaccine has one strain in common with last year's vaccine, plus two new viral strains.
The vaccine will be manufactured by six companies, including GlaxoSmithKline, Sanofi and Novartis.
According to the Centers for Disease Control and Prevention, between 5 and 20 percent of Americans get the flu each year, leading to 200,000 hospitalizations. Flu-related deaths vary each year and can range from 3,000 to 49,000.
The CDC recommends that everyone older than six months receive an annual flu vaccine.
(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)